This report is concerned with an assessment of the utility of the vital capacity in anticipating the occurrence of congestive heart failure in susceptible persons before overt symptoms and signs. To this end, an examination of the relation of routinely measured biennial vital capacities to subsequent incidence of clinically overt myocardial decompensation over the next two years was undertaken. In 5209 persons so evaluated over an 18 year period it was found that risk of congestive heart failure varied over a 10-fold range in inverse proportion to their vital capacity (standardized for height) in persons still free of clinical evidence of myocardial decompensation. Also, among persons at high risk of failure (due to coronary disease, hypertension or rheumatic heart disease) chances of developing congestive failure were doubled in men with low vital capacities and tripled in women.
SUMMARY
This report is concerned with an assessment of the utility of the vital capacity in anticipating the occurrence of congestive heart failure in susceptible persons before overt symptoms and signs. To this end, an examination of the relation of routinely measured biennial vital capacities to subsequent incidence of clinically overt myocardial decompensation over the next two years was undertaken. In 5209 persons so evaluated over an 18 year period it was found that risk of congestive heart failure varied over a 10-fold range in inverse proportion to their vital capacity (standardized for height) in persons still free of clinical evidence of myocardial decompensation. Also, among persons at high risk of failure (due to coronary disease, hypertension or rheumatic heart disease) chances of developing congestive failure were doubled in men with low vital capacities and tripled in women.
Examination of the net contribution of vital capacity to risk of congestive failure revealed that a low vital capacity was associated with development of congestive failure even after taking into account other contributing factors including blood pressure, relative weight, pulse rate, cigarette smoking, heart enlargement on X-ray, ECG-LVH, blood glucose and age. Both a persistently low and a recent fall in vital capacity were associated with increased risk of congestive failure. Obstructive lung disease was not a factor in either case since FEV,/total vital capacity (TVC) was unrelated to congestive heart failure incidence. The simple total vital capacity thus appears to have considerable utility as a practical, noninvasive office procedure for evaluating failing left ventricular performance. Additional Indexing Words: Prediction IT HAS LONG BEEN RECOGNIZED that the vital capacity (VC) becomes impaired as the lungs become engorged and turgid with blood consequent to a failing left ventricle, but most consider this decrease a late finding representing a manifestation of overt congestive failure. Measurement of VC has been recommended as a clinically useful tool for evaluating response to treatment in patients under medical management for congestive failure.'
The diagnosis of congestive failure (CHF) is in a primitive state requiring that the patient exhibit breathlessness, audible fluid in the lungs, pitting edema in dependent parts of the anatomy, elevated venous pressure in the neck veins, an enlarged heart, a gallop rhythm and evidence of impaired aeration of the lungs such as cyanosis. Considerable impairment of function can be present in the absence of any or all of these morbid phenomena.2 It would seem reasonable to attempt to detect impaired left ventricular function while some myocardial reserve still exists and there are compensatory mechanisms on which the heart can call. Assistance by judiciously administered inotropic agents and diuretics at this point may be more effective. Whether this will in fact delay the onset of overt failure and prolong life in persons with heart disease remains to be demonstrated. However, this would appear to hold more promise than management which is instituted only after overt congestive failure appears. It has been found in Framingham that the latter approach is associated with an appalling mortality. 3 The purpose of this report is to explore prospectively the efficacy of one simple, noninvasive office procedure as a detector of impending congestive failurethe total VC.
Method
This report is based upon 18 years of cardiovascular surveillance of a population cohort of 5209 men and women aged 30-62 at entry who were examined biennially for the Circulation, Volume XLIX, Jnne 1974 development of cardiovascular disease in relation to a variety of precursive factors believed to contribute to their occurrence. Included among the usual attributes measured was a total VC measured with a Collins Respirometer with the subject standing. The best of three efforts was used. Other factors measured at each biennial examination included: blood pressure, 13-lead ECGs, chest X-ray, blood lipid, sugar, relative weight, pulse rate and hematocrit determinations. A detailed cardiovascular history and physical examination was carried out by study personnel using structured forms to assure completeness and uniformity of assessments. In an effort to achieve diagnostic consistency all cardiovascular diagnoses were made using uniformly applied criteria, a second examiner to verify every suspected case of new disease, and a review of all cases identified at each biennial examination by a panel of investigators with access to all diagnostic information including not only the routine clinic findings, but all interim illness records. Hospital admission lists were checked daily to determine if study subjects were hospitalized and a copy of the hospital record obtained.
Detailed criteria for each of the major cardiovascular end points under consideration in the Framingham Study have been published elsewhere including the criteria for the diagnosis of congestive heart failure.4 To be accepted, the criteria could not be attributable to any other condition. Because a fall in VC was one of the criteria employed, all cases were reviewed to exclude those where acceptance was dependent on this finding. None were found.
Descriptions of the sampling procedure, methods used in the study, and analytical techniques employed have also been noted in detail elsewhere.4 Follow-up has been reasonably complete with only 2% completely lost after 18 years.
All persons with any stigmata of congestive failure definite, probable or questionable were excluded from the population at risk at the time of initial examination leaving 5192 men and women at risk. Also, at each biennial examination those who were found to have developed definite congestive heart failure were excluded and the rest placed at risk in relation to their total ye/height at the start of each biennium. Average annual incidence of congestive heart failure was computed in relation to person-years exposure to risk of congestive heart failure at a given level of VC in a given age-sex group. This shows the relationship of antecedent total VC in persons clinically free of congestive heart failure to its short term subsequent development.
In the evaluation of the short term incidence between one biennial examination and the next, persons are recharacterized according to ye/height and disease status at each subsequent biennial examination and shifted from one age group to the next as they grow older. The sum of this experience in the nine biennial follow-up intervals is expressed as an overall biennial incidence rate. This allows an expansion of the age-specific incidence experience using reexamination as a substitute for a much larger cohort. In computing person-years exposure at risk, contrary to the usual implication of this label, no account was taken of the fact that some persons are not at risk the full two years after an examination either because they died or developed congestive failure in the interval. The incidence rate is given as the number of events per 1000 person-years at risk for the first nine examinations.
Smoothed average annual incidence rates were computed based on the mean of the individual probabilities of Circulation. Volume XLIX, June 1974 developing congestive failure in the two years following the examination in relation to vital capacity determination at the beginning of the interval. The individual probability according to the value of the characteristic at examination and to the values of the intercept and regression coefficient was estimated by fitting a logistic function to the occurrence of the event in the age-sex group. The details of this procedure have been published elsewhere.4 Because VC is greatly influenced by stature, VC was expressed in deciliters per inch of height for each participant in this study. Height was used in preference to weight since the best prediction formulae for VC use age and height, and VC doesn't decrease much until weights exceeding 40% of ideal are reached.
Results
Over the 18 year period of biennial cardiovascular surveillance 97 men and 86 women aged 45-74 developed congestive heart failure meeting the criteria of the review panel. In the age group 35-44 there were only four cases each for men and women which were too few to allow for meaningful analysis. The incidence rose precipitously with age with a modest male predominance (table 1) .
Total VC was also an age related phenomenon and the characteristically higher VCs in men than women were noted. The decline in VC with age at any particular examination was pronounced. The decrease with age as one actually followed persons with repeated measurements was similar to that inferred from cross-sectional data ( fig. 1 ).
Thus, both VCs and incidence of CHF change with age, but at any age in either sex risk of congestive failure (in persons free of overt evidence of failure) was decidedly related to antecedent VC. Risk of congestive failure increased progressively the lower the VC at each biennial examination. The trends were significant in each age group for each sex and the association was more pronounced in women than men (tables 2, 3). 
Figure 1
Averaige age trends in vital capacity levels for cross-sectional and cohort data: Franminghani Study. exams 1-10.
Over the entire age range (making suitable adjustment for age stratification when persons are classified according to vital capacity) computed relative odds (odds = P/(1-p) ) reveal a 5-fold range at risk of CHF in men and 26-fold in women, in the univariate case in inverse proportion to the vital capacity ( fig. 2 ). Vital capacity predicted proximate failure better than failure at some point in the distant future. Regression coefficients were steeper for biennial incidence based on most recent VC than for CHF over the entire span of follow-up in relation to only the initial VC. This difference probably stems from the fact that repeated assessments take into account a fall in VC, which is in fact as well as by definition related to the diagnosis of the disease. The small number of subjects however, does not permit precise estimates of this effect. Examination of trends in VC among persons who developed congestive failure revealed that significant in both sexes about half the men and 60% of the women had distinctly low antecedent VCs (i.e., <3.0 liters men, and <2.0 liters women). In men, about half the low vital capacities represented a recent fall from higher values. In women, one third had a recent fall and the rest stable, low values. This would suggest that both a persistently low and a recent fall in VC are associated with increased propensity to congestive failure. This proved to be the case when a more formal regression analvsis was carried out to assess the net effect of change in vital capacity taking into account the starting level. In women, both the fall in VC and the starting level could be demonstrated to be related to CHF incidence (table 4). In men with the numbers available the relationship could be demonstrated for the level, but not the change in VC.
Evaluation of CHF events occurring some time remote from the VC measurement (2 to 18 years afterward) still reveals a significant relationship. This provides reassurance that the relationship demonstrated does not arise because of confusion of CHF criteria (which includes a fall in VC) with an independent association of VC with CHF incidence. It also suggests that persistently low values predispose and that VC is a long-term predictor as well as an indication of imminent failure (table 5).
In the case of those with persistently low values, obstructive pulmonary disease cannot be invoked as the explanation since risk of congestive failure was unrelated to the ratio of FEV1/TVC (table 6 ). In fact, there were very few cases of CHF attributed to cor pulmonale and in four of the six age-sex categories no one had chronic obstructive pulmonary disease (i.e., an FEV1/TVC of <60%).
Coronary and hypertensive heart disease together are responsible for 90% of congestive failure in men and 75% in women with the remainder largely due to rheumatic heart disease. Persons with such etiologies have about 10 times the general population's risk of congestive failure. Among such high risk persons the risk of congestive failure is not uniform and varies over a 40-fold range depending on such factors as heart size, ECG abnormality, height of systolic blood pressure, pulse rate and glucose tolerance. In view of the foregoing, it is not unreasonable to examine the utility of the VC in identifying, among those with an etiology for failure, those destined for failure within the next two years. To this end, persons with coronary disease, hypertension or rheumatic heart disease, but without clinical evidence of failure at each biennial examination were segregated from the general pop- Note: Percent change is from Exam X-1 to Exam X ([(X-1)-X]100). Incidence is from Exam X to Exam X + 1.
(X-1) The bivariate function has as the other variable the average vital capacity between (X-1) and X, which has an average t-value of -4.00 for men and -5.96 for women. To be included a person must have vital capacity determ nations on both Exam X-1 and Exam X. C'ircudatioi, Volume XLIX, Jutne 1974 ulation and placed at risk of congestive failure in the next two years in relation to their VC. This revealed that the chances of developing congestive failure were doubled in men with low vital capacities and tripled in women (table 7) . This was true at all ages. It thus appears that among persons already at high risk of failure as well as in the general population, the VC has considerable utility in selecting those in imminent danger.
It is conceivable that VC is related to CHF incidence only by virtue of its association with some other contributing factor. Examination of the correlation of VC with other relevant variables reveals only trivial correlations (table 8) . Most, however, are negative, suggesting that although small, there is a real association of low VCs with factors which reflect or promote cardiovascular disease. On the other hand, the low order correlations suggest that the effect of VC is not likely to be entirely explained by these factors. This is borne out in multivariate analysis (table 3) . Even accounting for blood pressure, relative weight, pulse rate, cigarette habit, ECG-LVH, heart size on Xray, age and blood glucose, risk is still prominently related to antecedent VC. Comparison of the univariate and multivariate coefficients reveals about a 50% reduction in the coefficient for the regression of CHF incidence on VC in the multivariate case when the other factors are taken into account (table 3) . There is still, however, a sizable and statistically significant residual gradient of risk left after other factors are accounted for ( fig. 2, table 3) .
No direct evidence is available from Framingham which links the VC to left ventricular function. Noninvasive techniques for assessing cardiac function were introduced too recently to attempt such an evaluation. There is one piece of evidence which was available that suggests that there may, in fact, be a correlation between VC and left ventricular function. Frontal plane cardiac area was measured on the chest X-ray on the fourth biennial examination. Enlargement of the heart is recognized as a sign of an overworked or decompensating heart. It is interesting to note that there is a distinct trend to larger hearts the lower the VC (table 9) . Also, the small but consistently negative correlation of VC with ECG abnormalities as well as cardiac enlargement on X-ray is suggestive of a relation to cardiac function (table 8) .
Discussion
More than a century ago Hutchinson published his classical paper on the VC of the lung5 but its clinical implications in the evaluation of dyspnea was not fully appreciated for half a century as reported by Peabody and Wentworth.6 Its use in the evaluation of cardiacs was finally vigorously promoted in 1949 by Samuel A. Levine.1 He found the VC a valuable index of progression in the decompensated cardiac and pointed out that in his clinical experience a falling VC indicated that heart failure was developing and that this will precede any obvious change in physical findings.' The findings of this study support his clinical impression. He also pointed out that the VC is more closely related to height than to surface area. This method of adjustment for individual stature is used in this report.
Examination of survival in congestive failure in Framingham revealed that despite modern management the probability of death within five years from onset was about 60% in men and 40% in women. 7 Clinical methods for assessing left ventricular dysfunction are primitive and capable of detecting only severe failure after the myocardium has used up all its reserve and the circulatory apparatus all its compensatory mechanisms. It is small wonder that pharmaceuticals employed at this stage achieve modest results and hold off the inevitable end stage of intractable failure and death for only a short time.
It is conceivable that corrective measures implemented at the earliest indications of impaired myocardial function might delay the appearance of ' tTrend is significant at P < .01 level (t = 3.55 for all ages combined).
('irculationz, volutne XLIX, June 1974 *Third decimal place is in the negative direction.
overt congestive failure. Before this idea can be tested noninvasive, atraumatic, accurate indicators of impaired myocardial function that are applicable in an outpatient or office setting will have to be developed. Vital capacity is a rather indirect way of approaching the problem of assessment of left ventricular performance in these days of development of more sophisticated noninvasive methods. However, those methods currently availablee.g., systolic time intervals,8 apex cardiography9 and echocardiographyare currently not office procedures, simple, inexpensive or readily available.
It appears that the monitoring of VC is one simple office procedure that deserves further investigation. In a person with hypertension and an enlarging heart, a Mean Heart Exam 4 falling VC would appear to be a harbinger of overt congestive failure at a time when clinical signs would not permit a confident diagnosis.
Possible mechanisms whereby VC might be diminished as a result of left ventricular dysfunction are decreased strength of the respiratory muscles, an increase in myocardial mass with or without concomitant rise in central and pulmonary vascular blood volume (thus leaving less of the fixed capacity of the thoracic cage for air volume), an increase in extravascular lung water, or changes in pulmonary mechanics such as decreased compliance or a larger closing volume.
Patients with early pulmonary congestion may complain of fatigue, but should be capable of producing In the normal upright lung, most of the ventilation and perfusion is distributed to the basal zones. With any increase in left atrial pressure, ventilation and perfusion start to shift cephalad owing to increased interstitial edema at the bases. Since the residual volume occupies a greater portion of the total lung capacity toward the apices, vital capacity must be reduced. 12 13 The decrease in lung compliance associated with pulmonary congestion is well known and is usually ascribed to the stiffness imparted by interstitial fluid accumulation. Also, in pulmonary edema or with decreased blood flow in the lungs (such as might occur in left ventricular dysfunction) there is decreased surfactant production, which in turn increases elastic recoil and decreases lung volumes.14 15 It seems reasonable to assume that patients destined to develop congestive heart failure go through a prodromal phase when there is modest left ventricular dysfunction and elevation of left atrial pressure, thus causing ventilation to shift toward the apices, where VC is proportionally lower, and causing compliance to decrease, also lowering VC. Therapy directed toward improving cardiac performance and reducing the afterload should, at this stage, result in reversal of the process and restoration of normal pulmonary and cardiac function. This might result in a delay in the appearance of symptoms of dyspnea on exertion and other overt manifestations of congestive failure.
The finding that a recent fall in VC predicts the occurrence of congestive failure is readily explained in terms of current concepts of derangement of pulmonary physiology in cardiovascular disease. The association of a persistently low value with an increased incidence of CHF is less readily explained. The fact that FEV,/TVC is in these persons unrelated to CHF incidence suggests that chronic obstructive pulmonary disease is not the explanation. This is supported by the fact that very few of the CHF cases were ascribed to overt cor pulmonale. A possible explanation is that, given a cause for CHF, those with a low VC (inherent or acquired) will exhibit symptoms of myocardial failure more readily than those with a high VC.
Whatever the mechanism, it is clear that VC is a useful procedure for evaluating patients likely to develop congestive failure. A low or decreasing VC in patients with an etiology for failure (particularly hypertensive and coronary disease) is a harbinger of impending congestive failure prior to the appearance of overt symptoms or signs of cardiac decompensation.
